reac-technology
Contact us
reac-technology
Contact us

Pioneering Neurodiversity Seminar to Debut in Brazil, Featuring REAC® Technology Founder Dr. Salvatore Rinaldi

Join a pioneering seminar in Brazil on neurodiversity, ASD, and ADHD, featuring keynote speaker Dr. Salvatore Rinaldi, founder of REAC® Technology

  • September 29, 2025
seminar-prof.-rinaldi-29-09-25

Natal, RN – Brazil is set to host an unprecedented event dedicated to neurodiversity, featuring the internationally acclaimed neurophysiopathologist, Dr. Salvatore Rinaldi. The “National Seminar on Neurodiversity: REAC® Technology and Public Policies for ASD, ADHD, and Other Conditions” will take place on September 29, 2025, from 7:00 PM to 9:00 PM at the Praiamar Arena Hotel in Natal, RN.

This landmark event aims to foster a multidisciplinary discussion on comprehensive care for neurodivergent individuals, with a special focus on those diagnosed with Autism Spectrum Disorder (ASD), and the challenges faced by their families.

The seminar’s highlight will be the international keynote address by Dr. Salvatore Rinaldi, the founder of the Rinaldi Fontani Institute in Florence, Italy. For over three decades, Dr. Rinaldi has been a leading figure in the scientific investigation of epigenetic changes—alterations in gene expression that do not involve changes to the DNA sequence itself. He is the creator of the groundbreaking REAC® (Radio Electric Asymmetric Conveyer) Technology, a pioneering method of neuromodulation and biomodulation.

“The greatest challenge in science today is not just to treat symptoms, but to help the body rediscover its natural capacity for self-regulation,” explains Dr. Rinaldi. “REAC® Technology was born from this pursuit: to reorganize compromised functions and open pathways to a better quality of life.”

This seminar marks the first time such an event will be held in Brazil, bringing together specialists from various fields to discuss science, health, and public policies for neurodiversity in an integrated manner. The event is expected to not only introduce new therapeutic perspectives but also to invigorate the conversation around inclusion, autonomy, and citizenship for neurodivergent people.

The seminar is tailored for a professional audience, including pediatricians, psychiatrists, neurologists, psychologists, neuropsychologists, speech therapists, occupational therapists, and educators. Students in the fields of health and education are also encouraged to attend. To accommodate all attendees, simultaneous translation from Italian to Portuguese will be provided.

Participation in the seminar is free of charge, but seating is limited and expected to fill up quickly. Registration is available through the Sympla platform.

https://www.sympla.com.br/evento/seminario-nacional-sobre-neurodiversidade/3124956?referrer=www.google.com

Did you find this article interesting? Share it!

Subscribe to the newsletter

reac-technology
Home About News
Contact us
© 2026 REAC® All rights reserved
Privacy Policy Terms of Use and Legal Notice
Manage Cookie Credits

Dr. Vania Fontani

dr-vania-fontani-rinaldi-fontani-institute

Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.

She has dedicated her career to research and the development of innovative technologies for human well-being.

Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.

In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.

Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity

Learn more:
• Publications: PubMed – Rinaldi S, Fontani V

Prof. Salvatore Rinaldi

dr-salvatore-rinaldi-rinaldi-fontani-institu

Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316

Profile and Mission

Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.

 

Research Milestones

Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:


Regenerative Medicine:

  • Direct cellular reprogramming through epigenetic modulation of
    endogenous bioelectrical activity with REAC technology.
  • Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle
    differentiation in mouse embryonic stem cells: a new tool for improving tissue
    regeneration. Cell Transplant. 2012;21(6):1225-33. doi: 10.3727/096368911X600966.
  • Radio electric conveyed fields directly reprogram human dermal skin fibroblasts
    toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant.
    2013;22(7):1227-35. doi: 10.3727/096368912X657297.
  • Neurological morphofunctional differentiation induced by REAC technology in PC12. A
    neuro protective model for Parkinson's disease. Sci Rep. 2015 May 15:5:10439. doi:
    10.1038/srep10439.

Anti-Senescence and Longevity:

  • REAC technology and hyaluron synthase 2, an interesting network to slow down stem
    cell senescence. Sci Rep. 2016 Jun 24:6:28682. doi: 10.1038/srep28682.
  • Stem cell senescence. Effects of REAC technology on telomerase-independent and
    telomerase-dependent pathways. Sci Rep. 2014 Sep 16:4:6373. doi:
    10.1038/srep06373.
  • Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age
    (Dordr). 2014 Feb;36(1):9-20. doi: 10.1007/s11357-013-9537-8.

Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:

  • REAC technology modifies pathological neuroinflammation and motor behaviour in an
    Alzheimer's disease mouse model. Sci Rep. 2016 Oct 24:6:35719. doi:
    10.1038/srep35719.
  • Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a
    Mouse Model of Neurodegeneration. Neurosci Bull. 2018 Apr;34(2):270-282. doi:
    10.1007/s12264-017-0188-0

Scientific Vision

Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.

Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V